6/16/2014 8:24:01 AM
TARRYTOWN, N.Y.--(BUSINESS WIRE)--PsychoGenics Inc. announced today that it has received a license to use the Cntnap2 knockout mouse from Yeda R&D Co. Ltd., the technology transfer company of the Weizmann Institute of Science. The CNTNAP2 gene encodes for Contactin Associated Protein 2 (Caspr2), a member of the neurexin family of cell recognition molecules. Mutations in this gene are associated with schizophrenia, autism, ADHD and language impairment.
Help employers find you! Check out all the jobs and post your resume.
comments powered by